The pharma sector has been on a stable growth trajectory lately, and the trend gathered momentum when the pandemic-related emergency made companies
Pfizer Inc.
-(PFE)
Get the latest Pfizer Inc. (PFE) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Biofrontera sees TAM of $4 Bln for lead product Ameluz: CEO Erica Monaco
Caption: iStock Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States. Founded in
IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO
After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing
Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook
Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom line also
Pfizer (PFE) stock research summary | Q3 2021
Pfizer delivered a solid performance in Q3 2021 with a triple-digit increase in revenue and profits growing many-fold. The company’s COVID-19 vaccine,
Pfizer (PFE): Comirnaty and a strong pipeline provides long-term growth opportunity
Shares of Pfizer Inc. (NYSE: PFE) gained 4% on Tuesday after the company delivered strong results for the third quarter of 2021
Pfizer Inc (PFE) Q3 2021 Earnings Call Transcript
Pfizer Inc (NYSE:PFE) Q3 2021 earnings call dated Nov. 02, 2021. Corporate Participants: Chris Stevo -- Senior Vice President and Chief Investment Relations Officer
Key highlights from Pfizer (PFE) Q3 2021 earnings results
Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today. Revenues more than doubled year-over-year to $24 billion. Reported net income
Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues
Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also
Pfizer (PFE) expects to manufacture up to 3 billion doses of COVID vaccine by end of this year
Shares of Pfizer Inc. (NYSE: PFE) were up 3.5% on Wednesday after the pharma giant reported second quarter 2021 revenue and earnings
Pfizer, Inc. (PFE) Q2 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo -- Senior Vice President, Chief Investor Relations Officer
Pfizer Inc. (PFE) Q2 2021 Earnings Call
Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo — Senior Vice President, Chief Investor Relations Officer Albert
Infographic: How Pfizer (PFE) performed in Q2 2021
Pfizer Inc. (NYSE: PFE) reported second quarter 2021 earnings results today. Total revenue increased 92% year-over-year to $19 billion. GAAP net income
Earnings calendar for the week of July 26
After showing weakness at the beginning of the week, benchmark stock indexes made steady gains even as economic recovery gathered steam. On
Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic
Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported Q1 revenue
Earnings calendar for the week of May 3
Leading stock indexes retreated after gaining mid-week when Wall Street biggies like Apple and Amazon reported impressive quarterly numbers. The Dow Jones
Two areas that provide Pfizer (PFE) with ample opportunity for future growth
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront of the
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete
These two factors will play out in favor of Pfizer (PFE) going forward
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past 12 months. The company had a huge win with